Focal Gains of VEGFA: Candidate Predictors of Sorafenib Response in Hepatocellular Carcinoma

Cancer Cell

Volumn 25, Issue 5, 2014, Pages 560-562

  Llovet, Josep M ^a,b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BRIVANIB; ERLOTINIB; SCATTER FACTOR; SORAFENIB; SUNITINIB; VASCULOTROPIN A;

CANCER PATIENT; DRUG RESPONSE; GENE AMPLIFICATION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOLECULAR THERAPY; NONHUMAN; PARACRINE SIGNALING; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SHORT SURVEY; STROMA CELL; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; GENE AMPLIFICATION; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER NEOPLASMS; MACROPHAGES; MICE; NIACINAMIDE; PHENYLUREA COMPOUNDS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84900320514     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2014.04.019     Document Type: Short Survey

References (10)

1. Bruix J., Raoul J.L., Sherman M., Mazzaferro V., Bolondi L., Craxi A., Galle P.R., Santoro A., Beaugrand M., Sangiovanni A., et al. J.Hepatol. 2012, 57:821-829.
2. Chiang D.Y., Villanueva A., Hoshida Y., Peix J., Newell P., Minguez B., LeBlanc A.C., Donovan D.J., Thung S.N., Solé M., et al. Cancer Res. 2008, 68:6779-6788.
3. Guichard C., Amaddeo G., Imbeaud S., Ladeiro Y., Pelletier L., Maad I.B., Calderaro J., Bioulac-Sage P., Letexier M., Degos F., et al. Nat. Genet. 2012, 44:694-698.
4. Horwitz E., Stein I., Andreozzi M., Nemeth J., Shoham A., Pappo O., Schweitzer N., Tornillo L., Kanarek N., Quagliata L., et al. Cancer Discov. 2014, Published online March 31, 2014. 10.1158/2159-8290.CD-13-0782.
5. Kwak E.L., Bang Y.J., Camidge D.R., Shaw A.T., Solomon B., Maki R.G., Ou S.H., Dezube B.J., Jänne P.A., Costa D.B., et al. N.Engl. J. Med. 2010, 363:1693-1703.
6. Llovet J.M., Hernandez-Gea V. Clin. Cancer Res. 2014, 20:2072-2079.
7. Llovet J.M., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J.F., de Oliveira A.C., Santoro A., Raoul J.L., Forner A., et al. N.Engl. J. Med. 2008, 359:378-390. SHARP Investigators Study Group.
8. Llovet J.M., Peña C.E., Lathia C.D., Shan M., Meinhardt G., Bruix J. Clin. Cancer Res. 2012, 18:2290-2300. SHARP Investigators Study Group.
9. Sawey E.T., Chanrion M., Cai C., Wu G., Zhang J., Zender L., Zhao A., Busuttil R.W., Yee H., Stein L., et al. Cancer Cell 2011, 19:347-358.
10. Villanueva A., Llovet J.M. Nat Rev. Clin. Oncol. 2014, 11:73-74.